AzTrials
AzTrials

Pain ManagementKHALPAINNCT07068672

Kaleidoscope and Helicone for Pain and Anxiety in Children

A study testing Kaleidoscope and Helicone in people with Pain Management and Procedural Pain, run by AYLİN ARIKAN at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aimed to evaluate the effects of kaleidoscope and helicone distraction tools on pain and anxiety levels during venipuncture in school-age children. The study was conducted at Ankara Etlik City Hospital Pediatric Emergency Department between April and May 2025. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Pain Management, Procedural Pain, Children
What is being tested?
Kaleidoscope and Helicone
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2025to 31 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children aged between 6 and 12 years
  • Requiring venipuncture for clinical purposes
  • Able to verbally communicate pain and anxiety
  • Accompanied by a parent or legal guardian who provides written informed consent
  • Child provides verbal assent to participate

Who cannot join

  • Children with cognitive or neurological disorders affecting pain or anxiety perception
  • Use of any analgesics, anxiolytics, or sedatives within 6 hours prior to the procedure
  • Visual or hearing impairments that interfere with the use of kaleidoscope or helicone
  • Previous experience with similar distraction tools
  • Presence of any skin condition preventing pain scale assessment

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara Etlik City Hospital

    Ankara, Etlik, 06270

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Kaleidoscope and Helicone Use on Pain and Anxiety During Venipuncture in School-Age Children: A Randomized Controlled Trial

This randomized controlled trial aimed to evaluate the effects of kaleidoscope and helicone distraction tools on pain and anxiety levels during venipuncture in school-age children. The study was conducted at Ankara Etlik City Hospital Pediatric Emergency Department between April and May 2025. A total of 210 children aged 6 to 12 years who were undergoing venous blood sampling for the first time were randomly assigned to one of three groups: Kaleidoscope, Helicone, or Control (standard care). The Kaleidoscope group used a passive distraction tool featuring dynamic visual patterns; the Helicone group used an active distraction tool that involves hand manipulation of a rotating toy. Pain levels were measured using the Wong-Baker FACES Pain Rating Scale, and anxiety levels were assessed using the Children's Anxiety Meter-State (CAM-S). Measurements were taken before, during, and after the procedure. This study seeks to determine the comparative effectiveness of active versus passive distraction techniques in pediatric procedural pain and anxiety management. All interventions were non-pharmacological, non-invasive, and conducted in a safe clinical setting with informed consent obtained from both children and their guardians.

Being tested
Kaleidoscope, Helicone
Keywords
Kaleidoscope, Helicone, Pediatric Pain Management, School-Age Children, Venipuncture
Medical subject headings
Agnosia, Pain, Procedural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KaleidoscopeBehavioural

    A handheld kaleidoscope was used as a passive distraction tool during venipuncture. The device was introduced to the child 2 minutes before the procedure and remained in view during blood collection. It provided dynamic, colorful visual stimuli to help reduce pain and anxiety.

  • HeliconeBehavioural

    A helicone toy was used as an active distraction tool. Children held and rotated the device beginning 2 minutes before and during venipuncture. The interactive movement and shape-shifting design engaged the child's attention to reduce procedural pain and anxiety.

Study groups in NCT07068672
Study groupRoleWhat they receive
Kaleidoscope GroupExperimentalChildren in this group were provided with a handheld kaleidoscope starting 2 minutes before and during venipuncture. The visual distraction created by the kaleidoscope's changing colorful patterns aimed to reduce pain and anxiety. The child focused on the visual display throughout the procedure.
Receives: Behavioral: Kaleidoscope
Helicone GroupExperimentalChildren in this group used a helicone toy starting 2 minutes before and during venipuncture. The toy, which changes shape with hand manipulation, provided active distraction to reduce pain and anxiety by engaging both visual and tactile senses.
Receives: Behavioral: Helicone
Control GroupNo interventionChildren in this group received standard care during venipuncture without any distraction tools. No visual or tactile distraction was provided.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain level measured using Wong-Baker FACES Pain Scale

    Pain was assessed by the child using the Wong-Baker FACES Pain Rating Scale. This scale ranges from 0 to 10, where higher scores indicate more severe pain. Evaluations were conducted at three time points: before the procedure, during needle insertion, and two minutes after.

    Measured: Two minutes before the procedure, during needle insertion, and two minutes after the procedure

  2. Anxiety level measured using Children's Anxiety Meter - State (CAM-S)

    Anxiety was evaluated using the Children's Anxiety Meter - State (CAM-S) tool. The scale ranges from 0 (no anxiety) to 10 (extreme anxiety). Assessments were completed by the child with assistance from the researcher at three time points: before, during, and after the venipuncture.

    Measured: Two minutes before the procedure, during needle insertion, and two minutes after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2025
  2. Study start1 Apr 2025
  3. Primary completion31 May 2025
  4. Study completion31 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
210 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07068672
Sponsor's protocol ID
AESH-B-2025-0123
Other IDs
AEŞH-BADEK-2025-0123
Acronym
KHALPAIN
Status last verified
Jul 2025
First submitted
7 Jul 2025
Last updated
18 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Kaleidoscope and Helicone in people with Pain Management and Procedural Pain, run by AYLİN ARIKAN at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain level measured using Wong-Baker FACES Pain Scale (time frame: Two minutes before the procedure, during needle insertion, and two minutes after the procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in